The Immunotherapy Series, Part Three: Policy and the FDA

The Immunotherapy Series, Part Three: Policy and the FDA

0 0 3 months ago
Immunotherapy and Policy. How can the FDA evolve to help advance and support novel approaches to medicine? How does the field of immune-driven diagnostics serve as a case in point for the need for evolution in existing regulatory frameworks?




Special guests:

Meghan Gutierrez

Chief Executive Officer

Lymphoma Research Foundation




Leo David Wang, M.D., Ph.D.

Assistant Professor, Department of Immuno-Oncology

Assistant Professor, Department of Pediatrics

City Of Hope




This series is ... See More

Find us on Facebook

iAB member
Copyright 2020 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help